scholarly journals Protocol on Causal Chain Analysis and Health Economic Modelling of Childhood Anaemia Interventions in Developing Countries - A Health Technology Assessment

2019 ◽  
Vol 8 (51) ◽  
pp. 3899-3903 ◽  
Author(s):  
Mahafroz Khatib ◽  
Mahalaqua Nazli Khatib ◽  
Mahjabeen Ahmed ◽  
Deepak Saxena ◽  
Unnikrishnan B ◽  
...  
Keyword(s):  
Health Economic ◽  
Developing Countries ◽  
Health Technology Assessment ◽  
Technology Assessment ◽  
Health Technology ◽  
Causal Chain ◽  
Economic Modelling ◽  
Chain Analysis ◽  
Health Economic Modelling

scholarly journals The Potential for Early Health Economic Modelling in Health Technology Assessment and Reimbursement DecisionMaking Comment on "Problems and Promises of Health Technologies: The Role of Early Health Economic Modeling"

2020 ◽  
Author(s):  
Hansoo Kim ◽  
Stephen Goodall ◽  
Danny Liew
Keyword(s):  
Health Economic ◽  
Health Technology Assessment ◽  
Technology Assessment ◽  
Health Technology ◽  
Economic Modelling ◽  
Broad Perspective ◽  
Health Technologies ◽  
Early Health ◽  
Health Economic Modelling

Grutters et al recently investigated the role of early health economic modelling of health technologies by undertaking a secondary analysis of health economic modelling assessments performed by their group. Our commentary offers a broad perspective on the potential utility of early health economic modelling to inform health technology assessment (HTA) and decision-making around reimbursement of new health technologies. Further we provide several examples to compliment Grutters and colleagues’ observations.

scholarly journals Implementing health technology assessment in Kuwait: a qualitative study of perceived barriers and facilitators

2019 ◽  
Vol 35 (6) ◽  
pp. 422-426 ◽  
Author(s):  
Basshar Darawsheh ◽  
Evi Germeni
Keyword(s):  
Developing Countries ◽  
Health Technology Assessment ◽  
Technology Assessment ◽  
Qualitative Interviews ◽  
Healthcare Providers ◽  
Health Technology ◽  
Barriers And Facilitators ◽  
Policy Makers ◽  
Face To Face ◽  
Key Stakeholders

AbstractObjectivesThis study sought to explore main barriers and facilitators to implementing health technology assessment (HTA) in Kuwait from the perspective of key stakeholders.MethodsSemi-structured qualitative interviews were conducted with ten key stakeholders: seven healthcare providers working at various departments of the Kuwaiti Ministry of Health (MOH), and three academics with substantial experience in teaching HTA or related fields. Interviews were conducted face-to-face, audio-recorded, and transcribed verbatim. Data were analyzed using an inductive thematic approach.ResultsParticipating stakeholders reported several factors that might act as a barrier to building HTA in Kuwait: minimal awareness of HTA, lack of institutional and human capacity, a fragmented healthcare system, poor communication between researchers and policy makers, the country's wealth, politics, as well as data quality, availability, and sharing. Institutionalizing HTA as a politically empowered body, enforcing its recommendation by law, and benefiting from neighboring countries' experiences were suggested as possible ways to move forward.ConclusionStudies exploring the unique challenges that high-income developing countries may face in implementing HTA are still scarce. The results of this study are consistent with evidence coming from other developing countries, while also suggesting that the abundance of financial resources in the country is a double-edged sword; it has the potential to facilitate the development of HTA capacity, but also hinders recognizing the need for it.

OP07 Real World Evidence: How Can It Improve Health Technology Assessment?

2018 ◽  
Vol 34 (S1) ◽  
pp. 2-3
Author(s):  
John Gillespie ◽  
Sebnem Erdol ◽  
Chris Foteff ◽  
Liesl Strachan
Keyword(s):  
Health Economic ◽  
Health Technology Assessment ◽  
Technology Assessment ◽  
Real World ◽  
New Technologies ◽  
Eligible Patient ◽  
Cost Effective ◽  
Health Technology ◽  
Economic Evaluations ◽  
Patient Pathways

Introduction:Health Technology Assessment (HTA) considers the question of whether evaluated technologies are cost-effective in real world settings. As observed in HTA conducted by the Australian Medical Services Advisory Committee (MSAC), questions regarding the validity of data inputs to economic analyses that reflect real-world practice is a common reason for uncertainty on the cost effectiveness of new technologies. In addition to resource use and costs, there may be other uncertainties regarding the eligible patient population, patient management pathways and comparator selection. Our objective in this study was to present case studies from Australia where real world linked datasets could be better utilized to inform HTA conducted by the MSAC.Methods:For selected therapy areas, assessment reports and public summary documents of HTA conducted by the MSAC published between January 2015 and November 2017 were reviewed. Our analysis identified HTAs where uncertainties around the inputs for health economic evaluations, as well as uncertainties in defining eligible patient numbers or current patient pathways of care were shown to exist. We then explored whether these uncertainties could have been addressed through real world linked datasets.Results:Our preliminary investigations identified two assessments: MSAC assessment of capsule endoscopy and transcatheter aortic valve implantation - where availability of real world linked data could have addressed uncertainties around the inputs required for the health economic evaluations.Conclusions:Australia has a range of real world datasets with the potential to be used to inform HTA conducted by the MSAC. This can only be achieved if the datasets could be better linked and accessible for use by key stakeholders in the MSAC HTA process (e.g. industry, clinician, patient societies). Use of these data sets in HTA will enable timelier patient access to cost-effective technologies and more effective implementation and review of technologies after adoption into clinical practice.

scholarly journals Historical development of health technology assessment in Thailand

2009 ◽  
Vol 25 (S1) ◽  
pp. 241-252 ◽  
Author(s):  
Yot Teerawattananon ◽  
Sripen Tantivess ◽  
Jomkwan Yothasamut ◽  
Pritaporn Kingkaew ◽  
Kakanang Chaisiri
Keyword(s):  
Public Health ◽  
Health Economic ◽  
Health Technology Assessment ◽  
Technology Assessment ◽  
National Policy ◽  
Health Benefit ◽  
Health Technology ◽  
Civil Society Organizations ◽  
Policy Makers ◽  
Health Technologies

Objectives: This study aims to review the development of health technology assessment (HTA), including the socioeconomic context, outputs, and policy utilization in the Thai setting.Methods: This study was conducted through extensive document reviews including these published in both domestic and international literature.Results: Evidence suggests that contextual elements of the health system, especially the country's economic status and health financing reforms, as well as their effects on government budgeting for medical and public health services, played an important role in the increasing needs and demands for HTA information among policy makers. In the midst of substantial economic growth during the years 1982 to 1996, several studies reported the rapid diffusion and poor distribution of health technologies, and inequitable access to high-cost technology in public and private hospitals. At the same time, economic analysis and its underpinning concept of efficiency were suggested by groups of scholars and health officials to guide national policy on the investment in health technology equipment. Related research and training programs were subsequently launched. However, none of these HTA units could be institutionalized into national bodies. From 1997 to 2005, an economic recession, followed by the introduction of a universal health coverage plan, triggered the demands for effective measures for cost containment and prioritization of health interventions. This made policy makers and researchers at the Ministry of Public Health (MOPH) pay increasing attention to economic appraisals, and several HTA programs were established in the Ministry. Despite the rising number of Thai health economic publications, a major problem at that period involved the poor quality of studies. Since 2006, economic recovery and demands from different interests to include expensive technologies in the public health benefit package have been crucial factors promoting the role of HTA in national policy decisions. Meanwhile, HTA capacity has been strengthened through the establishment of many health economic and HTA initiatives. An illustration of the work and contributions of the Health Intervention and Technology Assessment Program (HITAP) is provided. In this phase, HTA policy integration has been enhanced through different mechanisms and organizations.Conclusion: Over the past two decades a notable progression has been made in relation to the capacity building of HTA research and its policy utility in Thailand. Such development has been shaped by multiple factors. It is anticipated that experience gained among academics, health officials, and civil society organizations will be helpful not only in sustaining the momentum but also in improving formal HTA systems in the future.

scholarly journals Etica e Health Technology Assessment (HTA): sulle difficoltà della loro integrazione

2015 ◽  
Vol 64 (2) ◽  
Author(s):  
Pietro Refolo
Keyword(s):  
Health Economic ◽  
Health Technology Assessment ◽  
Technology Assessment ◽  
Health Technology ◽  
Research Field ◽  
Health Technologies ◽  
Legal Consequences

L’etica è stata da sempre considerata parte integrante dei processi di Health Technology Assessment (HTA), nel senso che la valutazione delle conseguenze di tipo etico relative all’impiego di tecnologie sanitarie rappresenta uno degli obiettivi fondamentali di questo settore di ricerca, alla stregua delle valutazioni sulla sicurezza, l’efficacia, l’impatto economico, quello organizzativo, socio-culturale e legale. A queste dichiarazioni di intenti non ha però corrisposto una effettiva attuazione nella pratica: l’etica non ha infatti avuto grande spazio nell’HTA e solo raramente le analisi etiche hanno trovato posto nei report. Sulle ragioni della difficoltà di integrare l’etica nell’HTA è stata avanzata una serie di ipotesi. Il presente articolo intende argomentare sull’ipotesi, secondo cui, alla base dell’insuccesso dell’integrazione dell’etica nell’HTA, vi sia anche e soprattutto un problema di natura epistemologica. ---------- Ethics has been identified as a key element in Health Technology Assessment (HTA) since its conception, meaning that examining ethical consequences – as well the health, economic, social-cultural and legal consequences – raised by the use of health technologies is a fundamental aim of this research field. Nevertheless, HTA rarely addresses ethics and ethical analyses have been rarely integrated explicitly in HTA reports. Many hypotheses have been provided to explain this lack. The article intends to discuss the hypothesis for which ethics is rarely integrated in HTA also and above all because of epistemological reasons.

Sign in / Sign up

Export Citation Format

Share Document